First Mercantile Trust’s Abiomed Inc ABMD Stock Holding History

First Mercantile Trust’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$117K	Sell	359 -26	-7%	-$8.81K	0.02%	606
2021 Q2	$120K	Buy	385 +137	+55%	+$42K	0.01%	630
2021 Q1	$79K	Sell	248 -12	-5%	-$3.84K	0.01%	731
2020 Q4	$84K	Sell	260 -21	-7%	-$5.81K	0.01%	727
2020 Q3	$79K	Sell	281 -55	-16%	-$15.8K	0.01%	725
2020 Q2	$81K	Sell	336 -9	-3%	-$1.81K	0.01%	727
2020 Q1	$50K	Sell	345 -13	-4%	-$2.16K	0.01%	707
2019 Q4	$61K	Sell	358 -454	-56%	-$84.2K	0.01%	774
2019 Q3	$145K	Buy	+812	New	+$176K	0.02%	587
2014 Q2	–	Sell	-42,239	Closed	-$1.1M	–	1281
2014 Q1	$1.1M	Buy	+42,239	New	+$1.17M	0.08%	335

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

First Mercantile Trust's ABMD Position: Q3 2021 in Review

First Mercantile Trust reduced its Abiomed Inc (ABMD) stake by 6.8% in Q3 2021, selling an estimated $8.81K and leaving 359 shares worth $117K. The position accounts for 0.02% of the portfolio, ranked #606.

First Mercantile Trust first reported a position in ABMD in Q1 2014 and has held it in 10 quarters since. The position peaked at $1.1M in Q1 2014. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

First Mercantile Trust held 359 shares of Abiomed Inc worth $117K as of Q3 2021.
First Mercantile Trust sold 26 Abiomed Inc shares in Q3 2021, an estimated $8.81K.
Abiomed Inc made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #606 holding.
First Mercantile Trust first reported a position in Abiomed Inc in Q1 2014 and has held it in 10 quarters since.
First Mercantile Trust's Abiomed Inc position peaked at $1.1M in Q1 2014.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.